<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01340404</url>
  </required_header>
  <id_info>
    <org_study_id>P071247</org_study_id>
    <nct_id>NCT01340404</nct_id>
  </id_info>
  <brief_title>Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy</brief_title>
  <acronym>DREPAGREFFE</acronym>
  <official_title>A Multicenter Study Comparing the Results of Allogeneic Stem Cell Genoidentical in Children With Sickle Cell Anemia and Cerebral Vascular Disease Detected by Transcranial Doppler</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to demonstrate that cerebral velocities assessed by transcranial
      doppler (TCD) are more significantly decreased by SCT than by long-term transfusion program A
      multicenter, national, non-randomized, prospective study of paired cohort will be conducted,
      with 2 groups of exposed (SCT) and non-exposed (TP) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to demonstrate that cerebral velocities assessed by transcranial
      doppler (TCD)are more significantly decreased by SCT than by long-term transfusion program A
      multicenter, national, non-randomized, prospective study of paired cohort will be conducted,
      with 2 groups of exposed (SCT) and non-exposed (TP) patients. Sixty-three patients will be
      enrolled, namely 21 sickle-cell patients in the &quot;SCT&quot; group and 42 in the &quot;Transfusion
      Program (TP)&quot; group
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebral vasculopathy</measure>
    <time_frame>1 year</time_frame>
    <description>velocity in the artery with highest velocity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ischemic lesions on magnetic resonance imaging (MRI)</measure>
    <time_frame>1 year</time_frame>
    <description>percentage of patients with ischemic lesions on magnetic resonance imaging (MRI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stenoses on magnetic resonance imaging (MRI)</measure>
    <time_frame>1 year</time_frame>
    <description>percentage of patients with stenoses on magnetic resonance imaging (MRI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>normalisation of arterial velocities</measure>
    <time_frame>12 months</time_frame>
    <description>percentage of patients at 1 year with velocities normalization on transcranial doppler (TCD)(&lt; 170 cm/sec)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>cognitive dysfunction</measure>
    <time_frame>12 months</time_frame>
    <description>the scale of cognitive dyfunction depends on the child's age : definition of dysfunction uses the WISC-4, WPPSI-4 or WAIS-3 according to age</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">63</enrollment>
  <condition>Sickle Cell Anemia</condition>
  <condition>Cerebrovascular Accident</condition>
  <arm_group>
    <arm_group_label>Stem Cell Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Transfusion program</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stem cell transplantation</intervention_name>
    <description>Stem cell transplantation</description>
    <arm_group_label>Stem Cell Transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transfusion program</intervention_name>
    <description>Transfusion program</description>
    <arm_group_label>Transfusion program</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sickle cell anemia patients (SS/Sb0)

          -  &lt; 15 years old

          -  History of abnormal transcranial doppler (TCD) (≥ 200 cm/sec)

          -  Siblings from the same parental couple

          -  Parents amenable to Human Leucocyte Antigen (HLA) typing, SCT if an HLA-identical
             sibling is available or to long-term transfusion program

        Exclusion Criteria:

          -  Sickle cell patients older than 15 years

          -  no history of abnormal transcranial doppler (TCD) (≥ 200 cm/sec)

          -  no sibling from the same parental couple

          -  parents averse to HLA typing, SCT if an HLA-identical sibling is available or to
             long-term transfusion program
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Françoise Bernaudin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHIC</name>
      <address>
        <city>Créteil</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2011</study_first_submitted>
  <study_first_submitted_qc>April 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2011</study_first_posted>
  <last_update_submitted>December 2, 2016</last_update_submitted>
  <last_update_submitted_qc>December 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Anemia, Sickle Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

